HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
Provided By GlobeNewswire
Last update: Nov 22, 2024
— Launch follows approval by Japanese Ministry of Health, Labour and Welfare in September 2024 —
— Milestone payment to be made to HUTCHMED from Takeda —
Read more at globenewswire.comNASDAQ:HCM (4/23/2025, 12:39:22 PM)
15.24
-0.36 (-2.31%)
Find more stocks in the Stock Screener
